Filed: 2/14/2025ACC: 0001085146-25-001501
📋 What this filing means
KYNAM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $1.69B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$1.69B
Total AUM (reported)
103.66M
Total Shares
Allocation by class
COM$1.06B62.9%
COM NEW$238.41M14.1%
TR UNIT$175.82M10.4%
CL A$61.66M3.6%
SHS$60.61M3.6%
ADS$36.15M2.1%
COM CL A$20.76M1.2%
Portfolio Concentration
Top 3$687.21M40.6%
4–10$599.76M35.4%
11–25$388.65M23.0%
Rest$16.23M1.0%
Top 3 weight
40.6%
Top 10 weight
76.1%
Voting Authority Distribution
Total shares with voting rights: 103.66M
Sole
Full voting authority
103.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
NATERA INC
SOLEShares2.02M
TypeSH
Market value$320.10M
18.92%
Sole
2.02M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares2.34M
TypeSH
Market value$191.29M
11.31%
Sole
2.34M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares300K
TypeSH
Market value$175.82M
10.39%
Sole
300K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares5.06M
TypeSH
Market value$127.97M
7.56%
Sole
5.06M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares8.52M
TypeSH
Market value$112.63M
6.66%
Sole
8.52M
Shared
0.00
None
0.00
DYNAVAX TECHNOLOGIES CORP
SOLEShares6.56M
TypeSH
Market value$83.78M
4.95%
Sole
6.56M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares2.52M
TypeSH
Market value$72.27M
4.27%
Sole
2.52M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares9.11M
TypeSH
Market value$71.02M
4.20%
Sole
9.11M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares9.09M
TypeSH
Market value$68.32M
4.04%
Sole
9.09M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.33M
TypeSH
Market value$63.76M
3.77%
Sole
3.33M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares1.46M
TypeSH
Market value$61.66M
3.64%
Sole
1.46M
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares4.90M
TypeSH
Market value$60.61M
3.58%
Sole
4.90M
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
SOLEShares1.76M
TypeSH
Market value$43.55M
2.57%
Sole
1.76M
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares1.23M
TypeSH
Market value$36.15M
2.14%
Sole
1.23M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares4.99M
TypeSH
Market value$33.21M
1.96%
Sole
4.99M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares1.80M
TypeSH
Market value$31.40M
1.86%
Sole
1.80M
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares2.27M
TypeSH
Market value$26.65M
1.58%
Sole
2.27M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares4.69M
TypeSH
Market value$20.76M
1.23%
Sole
4.69M
Shared
0.00
None
0.00
2SEVENTY BIO INC
SOLEShares5.95M
TypeSH
Market value$17.50M
1.03%
Sole
5.95M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.25M
TypeSH
Market value$15.26M
0.90%
Sole
1.25M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares390.79K
TypeSH
Market value$15.08M
0.89%
Sole
390.79K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares530.48K
TypeSH
Market value$7.37M
0.44%
Sole
530.48K
Shared
0.00
None
0.00
BURNING ROCK BIOTECH LTD
SOLEShares994.88K
TypeSH
Market value$6.72M
0.40%
Sole
994.88K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares3.64M
TypeSH
Market value$6.70M
0.40%
Sole
3.64M
Shared
0.00
None
0.00
AMARIN CORP PLC
SOLEShares12.41M
TypeSH
Market value$6.02M
0.36%
Sole
12.41M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NATERA INCSOLE | COM | 2.02M | SH | $320.10M 18.92% | 2.02M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 2.34M | SH | $191.29M 11.31% | 2.34M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 300K | SH | $175.82M 10.39% | 300K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 5.06M | SH | $127.97M 7.56% | 5.06M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 8.52M | SH | $112.63M 6.66% | 8.52M | 0.00 | 0.00 |
DYNAVAX TECHNOLOGIES CORPSOLE | COM NEW | 6.56M | SH | $83.78M 4.95% | 6.56M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 2.52M | SH | $72.27M 4.27% | 2.52M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 9.11M | SH | $71.02M 4.20% | 9.11M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 9.09M | SH | $68.32M 4.04% | 9.09M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.33M | SH | $63.76M 3.77% | 3.33M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 1.46M | SH | $61.66M 3.64% | 1.46M | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 4.90M | SH | $60.61M 3.58% | 4.90M | 0.00 | 0.00 |
BEAM THERAPEUTICS INCSOLE | COM | 1.76M | SH | $43.55M 2.57% | 1.76M | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 1.23M | SH | $36.15M 2.14% | 1.23M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 4.99M | SH | $33.21M 1.96% | 4.99M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 1.80M | SH | $31.40M 1.86% | 1.80M | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 2.27M | SH | $26.65M 1.58% | 2.27M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | COM CL A | 4.69M | SH | $20.76M 1.23% | 4.69M | 0.00 | 0.00 |
2SEVENTY BIO INCSOLE | COMMON STOCK | 5.95M | SH | $17.50M 1.03% | 5.95M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.25M | SH | $15.26M 0.90% | 1.25M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 390.79K | SH | $15.08M 0.89% | 390.79K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 530.48K | SH | $7.37M 0.44% | 530.48K | 0.00 | 0.00 |
BURNING ROCK BIOTECH LTDSOLE | SPONSORED ADS | 994.88K | SH | $6.72M 0.40% | 994.88K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 3.64M | SH | $6.70M 0.40% | 3.64M | 0.00 | 0.00 |
AMARIN CORP PLCSOLE | SPONS ADR NEW | 12.41M | SH | $6.02M 0.36% | 12.41M | 0.00 | 0.00 |
Page 1 of 2